Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00869921 · ClinicalTrials.gov registry record
Model 4195 Left Ventricular (LV) Lead Chronic Performance Study
A clinical trial, sponsored by Medtronic.
- Completed
- Registry status
- 1,322
- Enrollment target
NCT00869921: Completed study, sponsored by Medtronic.
NCT00869921 is a clinical trial that has completed, run by Medtronic. The registered enrollment target is 1,322 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00869921 has completed, sponsored by Medtronic.
- COMPLETED
- Registry status
- 1,322 participants
- Enrollment target
Study Summary
Evaluate long-term performance of the 4195 LV Lead. This evaluation is based on the number of lead-related complications occuring during the study compared to the number of leads enrolled in the study. The leads will be followed for 5 years after implant. This study is required by FDA as a condition of approval of the Model 4195 LV Lead and is integrated within Medtronic's post-market surveillance platform.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,322 participants |
| Start Date | 2009-03 |
| Est. Completion | 2018-04-03 |
What the finished NCT00869921 record still lists
NCT00869921 is an observational study that tracks outcomes without assigning an intervention. Its 1,322 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT00869921 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00869921 about?
NCT00869921 is a clinical study titled "Model 4195 Left Ventricular (LV) Lead Chronic Performance Study". Evaluate long-term performance of the 4195 LV Lead. This evaluation is based on the number of lead-related complications occuring during the study compared to the number of leads enrolled in the study. The leads will be followed for 5 years after implant. This study is required by FDA as a condition...
What is the current status of trial NCT00869921?
This trial is currently completed. The enrollment target is 1,322 participants. The study started on 2009-03. Estimated completion is 2018-04-03.
Who is sponsoring clinical trial NCT00869921?
This trial is sponsored by Medtronic, which has 30 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05097287 · 1,324 participants · Phase 4
Study Assessing the Long-term Effect of Dupilumab on Prevention of Lung Function Decline in Adult Patients With Uncontrolled Moderate to Severe Asthma
- NCT06557005 · 1,320 participants · NA
Facilitated Transitions From Postpartum to Primary Care Coordination for People With Chronic Conditions
- NCT07213908 · 1,320 participants · NA
Comparing Two School-Based Sleep Health Interventions To Promote Sleep Quality in Youth
- NCT07144800 · 1,319 participants · NA
Family COMIDA (Consumo de Opciones Más Ideales De Alimentos) (Eating More Ideal Food Options)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia